日本感冒类汉方制剂处方标准和上市情况分析  

Analysis on prescription standard and marketing situation of Japanese cold medicine Kampo preparations

作　　者：董晨东 王勇 DONG Chen-dong;WANG Yong(China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.,Shenzhen 518110,China)

机构地区：[1]华润三九医药股份有限公司,广东深圳518110

出　　处：《中草药》2021年第22期7072-7077,共6页Chinese Traditional and Herbal Drugs

摘　　要：通过梳理日本汉方目录中的感冒药并查阅日本感冒药汉方制剂的文献、官方政策与标准等,分析日本感冒药汉方制剂的处方标准,并对其上市批准文号与生产厂家进行整理。日本感冒药汉方制剂相关标准收载的内容较为详细,制剂种类与生产厂家数量较多,其中颗粒剂最为成熟。建议加快建立我国古代经典名方关键信息,对治疗常见病的经典名方上市应用给予更多关注,并为经典名方剂型开发与改善提供有益借鉴。The prescription standards of Japanese cold medicine Kampo preparations were analyzed and their marketing approval numbers and manufacturers were sorted out by combing through the cold medicines in the Japanese Kampo catalogue and consulting the literature,official policies and standards of Japanese cold medicine Kampo preparations in this paper.The contents contained in the relevant standards of Japanese cold medicine Kampo preparations are more detailed,with a large number of preparations and manufacturers,of which granules are the most mature.It is recommended to speed up the formulation of key information of ancient classic prescriptions in China,pay more attention to application of classic prescriptions in treatment of common diseases,and provide effective reference for development and improvement of classic prescriptions.

关 键 词：汉方制剂 感冒药 品种分析 处方标准 上市情况 古代经典名方 

分 类 号：R288[医药卫生—中药学]